Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns.

Group A streptococcal infections, ranging from necrotizing fasciitis and myositis to toxic shock syndrome, have increased over the last 10 years. We developed the first primate model of necrotizing fasciitis and myositis. Thirteen baboons were inoculated intramuscularly with group A streptococci (GAS). Eleven animals survived for > or = 11 days before sacrifice, and two animals died within 2 days. The site of inoculation of the survivors exhibited an intense neutrophilic influx (stage I), followed by a lymphoplasmacytic influx (stages II and III). This was accompanied by the appearance of markers of an acute and then a chronic systemic inflammatory response. In contrast, the site of inoculation of the two nonsurvivors exhibited intravascular aggregates of neutrophils at its margin with no influx of neutrophils and with extensive bacterial colonization. We conclude that GAS inoculation induces a local and systemic acute neutrophilia followed by a chronic lymphoplasmacytic response; failure, initially, of neutrophilic influx into the site of inoculation predisposes to systemic GAS sepsis and death; and this three-stage primate model approximates the human disease.

[1]  M. Awad,et al.  Clostridial Gas Gangrene: Evidence That α and θ Toxins Differentially Modulate the Immune Response and Induce Acute Tissue Necrosis , 1997 .

[2]  A. Nather,et al.  Streptococcal necrotizing myositis: a rare entity. A report of two cases. , 1997, Clinical orthopaedics and related research.

[3]  C. Hack,et al.  Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. , 1996, Blood.

[4]  R. Colman,et al.  Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. , 1996, Blood.

[5]  D. Stevens,et al.  Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. , 1996, The Journal of infectious diseases.

[6]  M. Boermeester,et al.  Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. , 1995, Archives of surgery.

[7]  C. Hack,et al.  Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons. , 1995, The Journal of infectious diseases.

[8]  L. Aarden,et al.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production , 1995, The Journal of experimental medicine.

[9]  F. Taylor,et al.  Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli. , 1994, Circulatory shock.

[10]  G. Zimmerman,et al.  Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. , 1993, FEMS immunology and medical microbiology.

[11]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[12]  C. Hack,et al.  Interleukin-8 in sepsis: relation to shock and inflammatory mediators , 1992, Infection and immunity.

[13]  D. Stevens,et al.  Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes. , 1992, The Journal of infectious diseases.

[14]  D. Stevens,et al.  Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. , 1992, The Journal of infectious diseases.

[15]  R. Colman,et al.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. , 1992, The Journal of laboratory and clinical medicine.

[16]  A. D. de Vos,et al.  Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. , 1991, Journal of immunological methods.

[17]  C. Hack,et al.  PAI-1 Synthesis in the Human Hepatoma Cell Line Hep G2 Is Increased by Cytokines - Evidence that the Liver Contributes to Acute Phase Behaviour of PAI-1 , 1991, Thrombosis and Haemostasis.

[18]  P. Schlievert,et al.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. , 1989, The New England journal of medicine.

[19]  M. Barnham Invasive streptococcal infections in the era before the acquired immune deficiency syndrome: a 10 years' compilation of patients with streptococcal bacteraemia in North Yorkshire. , 1989, The Journal of infection.

[20]  R. Warren,et al.  Streptococcus pyogenes bacteraemia in Cambridge--a review of 67 episodes. , 1988, The Quarterly journal of medicine.

[21]  R. Khatib,et al.  Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature. , 1987, Reviews of infectious diseases.

[22]  J. Cajot,et al.  Mapping of Epitopes on Human Tissue-Type Plasminogen Activator with Recombinant Deletion Mutant Proteins , 1987, Thrombosis and Haemostasis.

[23]  C. Kauffman,et al.  Group A streptococcal bacteremia in intravenous drug abusers. , 1985, The American journal of medicine.

[24]  D. Brackett,et al.  Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion. , 1983, The Journal of trauma.

[25]  L. L. Smith,et al.  The changing pattern of hemolytic streptococcal gangrene. , 1982, Archives of surgery.

[26]  Trence Dl,et al.  Beta-hemolytic streptococcal bacteremia in adults: association with cold weather in Minnesota. , 1981 .

[27]  T. W. Wu,et al.  Multilayer film elements for clinical analysis: applications to representative chemical determinations. , 1978, Clinical Chemistry.

[28]  J. Washington,et al.  Group A -hemolytic streptococcemia. Bacteriologic and clinical study of 44 cases. , 1973, Mayo Clinic proceedings.

[29]  G. Engh,et al.  Overwhelming sepsis associated with group A beta hemolytic streptococci. , 1971, The Journal of bone and joint surgery. American volume.

[30]  D. Armstrong,et al.  Group A β-Hemolytic Streptococcus Bacteremia in a Cancer Hospital , 1970 .

[31]  R. Duma,et al.  STREPTOCOCCAL INFECTIONS: A Bacteriologic and Clinical Study of Streptococcal Bacteremia , 1969 .

[32]  S. Rosalki An improved procedure for serum creatine phosphokinase determination. , 1967, The Journal of laboratory and clinical medicine.

[33]  G. Weissmann,et al.  MOTION PICTURE STUDY OF THE TOXIC ACTION OF STREPTOLYSINS ON LEUCOCYTES , 1963, The Journal of experimental medicine.

[34]  F. Wróblewski,et al.  Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  I. T. Oliver A spectrophotometric method for the determination of creatine phosphokinase and myokinase. , 1955, The Biochemical journal.

[36]  Diseases of Infancy and Childhood , 1955 .

[37]  F. Ingelfinger,et al.  SIGNIFICANCE OF HEMOLYTIC STREPTOCOCCIC BACTEREMIA: A STUDY OF TWO HUNDRED AND FORTY-SIX PATIENTS , 1937 .

[38]  F. Meleney HEMOLYTIC STREPTOCOCCUS GANGRENE , 1924 .

[39]  D. Stanley Tietz Textbook of Clinical Chemistry , 1999 .

[40]  M. Awad,et al.  Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. , 1997, The Journal of infectious diseases.

[41]  C. Hack,et al.  Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. , 1995, American journal of respiratory and critical care medicine.

[42]  C. Hack,et al.  Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. , 1993, Circulatory shock.

[43]  D. Stevens Invasive group A streptococcus infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  H. Braunstein,et al.  Characteristics of group A streptococcal bacteremia in patients at the San Bernardino County Medical Center. , 1991, Reviews of infectious diseases.

[45]  Martin Pr,et al.  Streptococcal Serogroup: A Epidemic in Norway 1987–1988 , 1990 .

[46]  E. Høiby,et al.  Streptococcal serogroup A epidemic in Norway 1987-1988. , 1990, Scandinavian journal of infectious diseases.

[47]  P. Ispahani,et al.  Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. , 1988, The Journal of infection.

[48]  Mike Korpics Streptococcal myositis: Adams EM, Gudmundsson S, Yocum DE, et al. Arch Intern Med 1985; 145:1020–1023 , 1986 .

[49]  L. Kaplan,et al.  Clinical Chemistry: Theory, Analysis, and Correlation , 1984 .

[50]  D. Gerding,et al.  Beta-hemolytic streptococcal bacteremia in adults: association with cold weather in Minnesota. , 1981, Minnesota medicine.

[51]  S. Svane Peracute spontaneous streptococcal myositis. A report on 2 fatal cases with review of literature. , 1971, Acta chirurgica Scandinavica.